Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norfloxacin and Probiotics on Portal Pressure in Cirrhosis
NCT01134692Phase 3Unknown
- Sponsor
- Govind Ballabh Pant Hospital
- Modality
- Small Molecules, Multi-strain Products
- Countries
- 1
01
Overview
A Phase 3 trial of norfloxacin, VSL#3 in Cirrhosis, Portal Hypertension (PH), esophageal varices, sponsored by Govind Ballabh Pant Hospital. Status: unknown.
02
Drugs
norfloxacinVSL#3
03
Conditions
CirrhosisPortal Hypertension (PH)esophageal varices
Beyond the preview
Go deeper on NCT01134692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134692.